stoxline Quote Chart Rank Option Currency Glossary
  
Laboratory Corporation of America Holdings (LH)
215.69  0.22 (0.1%)    02-27 16:00
Open: 214.96
High: 216.46
Volume: 1,052,432
  
Pre. Close: 215.47
Low: 212.15
Market Cap: 18,096(M)
Technical analysis
2024-02-27 4:17:12 PM
Short term     
Mid term     
Targets 6-month :  260.34 1-year :  268.1
Resists First :  222.89 Second :  229.53
Pivot price 220.71
Supports First :  212.14 Second :  176.5
MAs MA(5) :  217.19 MA(20) :  221.24
MA(100) :  215.47 MA(250) :  206.78
MACD MACD :  -1.9 Signal :  -1.1
%K %D K(14,3) :  21 D(3) :  24.8
RSI RSI(14): 41.2
52-week High :  234.08 Low :  179.58
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ LH ] has closed above bottom band by 18.6%. Bollinger Bands are 43.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 221.62 - 222.71 222.71 - 223.59
Low: 211.89 - 213.37 213.37 - 214.57
Close: 213.42 - 215.64 215.64 - 217.44
Company Description

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Headline News

Tue, 27 Feb 2024
SVB Leerink Begins Coverage on Laboratory Co. of America (NYSE:LH) - AmericanBankingNEWS

Tue, 27 Feb 2024
Laboratory Corp. Of America Holdings (LH) Annual Report Sheds Light on Revenue and Profit - AmericanBankingNEWS

Tue, 27 Feb 2024
Decoding Laboratory Corp of America Holdings (LH): A Strategic SWOT Insight - GuruFocus.com

Mon, 26 Feb 2024
Laboratory Corp. of America Holdings stock underperforms Monday when compared to competitors - MarketWatch

Mon, 26 Feb 2024
Here's Why Investors Should Hold Labcorp (LH) Stock for Now - Yahoo Finance

Sun, 25 Feb 2024
Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72 - Simply Wall St

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Diagnostics & Research
Shares Out 84 (M)
Shares Float 84 (M)
Held by Insiders 0.2 (%)
Held by Institutions 98.6 (%)
Shares Short 2,500 (K)
Shares Short P.Month 3,540 (K)
Stock Financials
EPS 4.34
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 93.86
Profit Margin 3.4 %
Operating Margin 7.5 %
Return on Assets (ttm) 3.8 %
Return on Equity (ttm) 4.2 %
Qtrly Rev. Growth -17.4 %
Gross Profit (p.s.) 0
Sales Per Share 144.93
EBITDA (p.s.) 20.26
Qtrly Earnings Growth 0 %
Operating Cash Flow 1,330 (M)
Levered Free Cash Flow 1,260 (M)
Stock Valuations
PE Ratio 49.69
PEG Ratio 1.5
Price to Book value 2.29
Price to Sales 1.48
Price to Cash Flow 13.6
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android